.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Queensland Health
Cantor Fitzgerald
Deloitte
AstraZeneca
Argus Health
Mallinckrodt
Harvard Business School
Chubb
Medtronic

Generated: June 27, 2017

DrugPatentWatch Database Preview

Nitrofurantoin, macrocrystalline - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for nitrofurantoin, macrocrystalline and what is the scope of nitrofurantoin, macrocrystalline patent protection?

Nitrofurantoin, macrocrystalline
is the generic ingredient in three branded drugs marketed by Alvogen Malta, Sun Pharm Inds, Mylan, Sandoz, Watson Labs, Impax Labs Inc, and Actavis Labs Fl Inc, and is included in eleven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Thirty suppliers are listed for this compound.

Summary for Generic Name: nitrofurantoin, macrocrystalline

Tradenames:3
Patents:1
Applicants:7
NDAs:11
Suppliers / Packagers: see list30
Bulk Api Vendors: see list48
Clinical Trials: see list20
Patent Applications: see list6,331
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:nitrofurantoin, macrocrystalline at DailyMed

Pharmacology for Ingredient: nitrofurantoin, macrocrystalline

Ingredient-typeNitrofurans
Drug ClassNitrofuran Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen Malta
MACRODANTIN
nitrofurantoin, macrocrystalline
CAPSULE;ORAL016620-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe
Watson Labs
NITROFURANTOIN MACROCRYSTALLINE
nitrofurantoin, macrocrystalline
CAPSULE;ORAL070249-001Jun 24, 1988DISCNNoNo► Subscribe► Subscribe
Sun Pharm Inds
NITROFURANTOIN
nitrofurantoin, macrocrystalline
CAPSULE;ORAL201722-002Feb 16, 2016ABRXNoNo► Subscribe► Subscribe
Sandoz
NITROFURANTOIN
nitrofurantoin, macrocrystalline
CAPSULE;ORAL074336-001Jan 25, 1995DISCNNoNo► Subscribe► Subscribe
Watson Labs
NITROFURANTOIN MACROCRYSTALLINE
nitrofurantoin, macrocrystalline
CAPSULE;ORAL070248-001Jun 24, 1988DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Boehringer Ingelheim
Fish and Richardson
Harvard Business School
Cantor Fitzgerald
Cipla
UBS
Express Scripts
Fuji
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot